Network origin in Vincent Sai first degree
Entity | Entity type | Industry | |
---|---|---|---|
SonALAsense, Inc.
SonALAsense, Inc. BiotechnologyHealth Technology SonALAsense, Inc. provides ALA Sonodynamic Therapy for the treatment of Glioblastoma Multiforme. The company was founded by Stuart Marcus and is headquartered in Berkeley, CA.
3
| Holding Company | Biotechnology | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Vincent Sai via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
DUSA Pharmaceuticals, Inc.
DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
DaIIchi Pharma Holdings, Inc. | Corporate Officer/Principal | ||
NFlection Therapeutics, Inc.
NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | Biotechnology | Founder | |
FIBRX Derm, Inc.
FIBRX Derm, Inc. Pharmaceuticals: MajorHealth Technology FIBRX Derm, Inc. develops anti-scarring therapeutic for patients with Dystrophic Epidermolysis Bullosa. The company was founded by Mark de Souza, James W. Fordyce and Erkki Ruoslahti and is headquartered in Berkeley, CA. | Pharmaceuticals: Major | Founder | |
SeylanMED LLC
SeylanMED LLC Miscellaneous Commercial ServicesCommercial Services SeylanMED LLC operates as a private biopharmaceutical company that develops a targeted therapy for Seborrheic Keratosis. The company as founded by Victor Neel and Anna Mandinova and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Chief Executive Officer | |
Chromaderm, Inc.
Chromaderm, Inc. BiotechnologyHealth Technology Chromaderm, Inc. operates as a clinical stage biotech company. It develops topical PKC-beta inhibitor. The company was founded by Barbara A. Gilchrest, Mark de Souza and James W. Fordyce and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
SeylanMED, Inc.
SeylanMED, Inc. BiotechnologyHealth Technology SeylanMED, Inc. engages in the development of topical akt inhibitor as a treatment for seborrheic keratosis. The company was founded by Victor Neel and Anna Mandinova and is headquartered in Berkeley, CA. | Biotechnology | Chief Executive Officer | |
Phoenicis Therapeutics, Inc.
Phoenicis Therapeutics, Inc. BiotechnologyHealth Technology Phoenicis Therapeutics, Inc. is a private company that is focused on developing therapies for rare dermatological disorders. The company is based in Hingham, MA. The company's goal is to improve the lives of those who suffer from these conditions. The CEO of the company is Deborah Ramsdell. | Biotechnology | Director/Board Member | |
NF2 Therapeutics, Inc.
NF2 Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services NF2 Therapeutics, Inc. develops therapies. The American company was founded by Michael Wootton, Mark P de Souza, Scott Plotkin. Michael Wootton has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder |
Statistics
International
United States | 11 |
Sectoral
Health Technology | 8 |
Commercial Services | 3 |
Operational
Chief Executive Officer | 6 |
Founder | 6 |
Director/Board Member | 5 |
President | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Most connected contacts
Insiders | |
---|---|
Mark de Souza | 9 |
Stuart L. Marcus | 3 |
Anna Houlihan | 1 |
- Stock Market
- Insiders
- Vincent Sai
- Company connections